Berkeley Lights (NASDAQ:BLI – Get Rating) released its earnings results on Monday. The company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.01), MarketWatch Earnings reports. The business had revenue of $20.20 million for the quarter, compared to analyst estimates of $20.22 million. Berkeley Lights had a negative return on equity of 31.78% and a negative net margin of 84.00%. Berkeley Lights’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the company earned ($0.24) earnings per share.
Shares of NASDAQ:BLI opened at $4.45 on Tuesday. Berkeley Lights has a 52 week low of $4.28 and a 52 week high of $51.28. The company’s 50 day moving average is $6.18 and its two-hundred day moving average is $12.42. The company has a current ratio of 7.04, a quick ratio of 6.60 and a debt-to-equity ratio of 0.09. The company has a market cap of $301.80 million, a PE ratio of -4.16 and a beta of 2.41.
In related news, Director Jessica Hopfield bought 80,000 shares of the company’s stock in a transaction that occurred on Thursday, March 10th. The shares were purchased at an average cost of $6.28 per share, with a total value of $502,400.00. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 20.30% of the company’s stock.
A number of equities research analysts have issued reports on BLI shares. Zacks Investment Research lowered shares of Berkeley Lights from a “hold” rating to a “sell” rating in a report on Wednesday, April 27th. Morgan Stanley dropped their price objective on shares of Berkeley Lights from $20.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Friday, February 25th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $23.25.
About Berkeley Lights (Get Rating)
Berkeley Lights, Inc, a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software.
- Get a free copy of the StockNews.com research report on Berkeley Lights (BLI)
- Follow The Money To Cigna
- Intuitive Surgical is an Intuitive Buy
- The Low In Lordstown Motors May Not Be The Last
- MarketBeat Podcast: Barbell Strategy To Strengthen Your Portfolio
- Institutional Support For Tyson Foods Is Growing
Receive News & Ratings for Berkeley Lights Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Berkeley Lights and related companies with MarketBeat.com's FREE daily email newsletter.